Eli Lilly plans to file for global regulatory approval of its next-generation obesity treatment, retatrutide, in the first quarter of 2027 after the weekly injection succeeded in two additional late-stage …
Tag:
Biotech and Pharmaceuticals
-
-
Novo Nordisk and Vivani Partner on Year-Long Implant Novo Nordisk has entered into a research collaboration with medical technology firm Vivani Medical to develop a long-acting, implantable delivery system for …
-
The U.S. Food and Drug Administration (FDA) has authorized Philip Morris-owned Swedish Match to market 20 Zyn nicotine pouch products as modified-risk tobacco products. This regulatory decision permits the company …
-
Fourteen Months Off the Clock The U.S. Food and Drug Administration has launched the PreCheck pilot program, a move aimed at accelerating the approval of domestic pharmaceutical manufacturing facilities. By …
-
Centene Announces Voluntary Separation Program Amid Financial Strains Centene Corporation, the largest Medicaid provider in the United States, announced a Voluntary Separation Program (VSP) for employees on Monday, citing challenges …
-
Pharmaceutical manufacturers are rapidly shifting their obesity drug pipelines toward oral medications and infrequent dosing schedules to capture a larger share of the global weight-loss market. While Eli Lilly and …
-
The U.S. Department of Agriculture is mobilizing resources to contain the New World screwworm following the confirmed detection of the parasite in Texas. As of June 2026, the USDA has …
-
Strengthening Public Health: Surveillance and Response to Contagious Diseases in U.S. Cities As the threat of highly contagious diseases like measles and respiratory viruses continues to evolve, U.S. Cities are …
-
Innovent Biologics and Pfizer Announce $10.5 Billion Oncology Partnership Shares of Hong Kong-listed Innovent Biologics surged on Friday following the announcement of a massive global licensing and collaboration agreement with …
-
TrumpRx Expands: Platform Adds Generic Drugs and New Pharmacy Tools The Trump administration is scaling its direct-to-consumer drug pricing platform, TrumpRx.gov, with a significant expansion of its offerings. On Monday, …
Newer Posts